Supraventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Supraventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Clinical Cohort Study - TRUST
TRUST is a clinical cohort study that is currently recruiting to investigate various cardiac arrhythmias. The document lists conditions incl…
-
FDA approval · 2025-02-21FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
The FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) from Baxter Healthcare Company.
-
FDA approval · 2025-02-21FDA Approved: DILTIAZEM HYDROCHLORIDE IN SODIUM CHLORIDE — Original Application (WG Critical Care, LLC)
FDA approved a new injectable diltiazem hydrochloride in sodium chloride under an original NDA from WG Critical Care, LLC. This parenteral f…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Safety and Efficacy of Paramedic Treatment of Regular Supraventricular Tachycardia [NA]
A completed clinical trial evaluated the safety and efficacy of paramedic treatment for regular supraventricular tachycardia.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia [Phase 3]
Phase 3 trial evaluating etripamil nasal spray for self-administered termination of spontaneous episodes of paroxysmal supraventricular tach…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Differentiate AVNRT from Orthodromic AVRT [NA]
A clinical trial from Assiut University aims to differentiate atrioventricular nodal reentrant tachycardia from orthodromic AV reciprocating…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping. [NA]
This clinical trial update indicates recruitment is ongoing for a study that aims to localize anatomical structures involved in nodal tachyc…
-
FDA approval · 2024-10-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic diltiazem hydrochloride under an Original Application (ANDA).
-
FDA approval · 2024-10-17FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Propafenone Hydrochloride filed by Strides Pharma Science Limited, adding a approved generic…
-
FDA approval · 2024-10-15FDA Approved: ESMOLOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA supplemental approval for Amneal's esmolol hydrochloride in sodium chloride, a generic injectable product.
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia [NA]
The trial updates the completion of a study evaluating a novel Valsalva assist device for terminating supraventricular tachycardia.
-
FDA approval · 2024-09-09FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride (Hospira, Inc.), confirming it as an approved generic drug under an ANDA…
-
FDA approval · 2024-07-09FDA Approved: ESMOLOL HYDROCHLORIDE — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for esmolol hydrochloride from Eugia US LLC, authorizing changes to the approved product under a…
-
FDA approval · 2024-07-09FDA Approved: ESMOLOL HYDROCHLORIDE — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for esmolol hydrochloride in sodium chloride (Esmolol Hydrochloride in Sodium Chloride) filed by…
-
FDA approval · 2023-03-07FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved Slate Run Pharmaceuticals, LLC's generic diltiazem hydrochloride through an original ANDA.
-
FDA approval · 2023-03-01FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith's generic diltiazem hydrochloride (Original Application) as a generic version of diltiazem hydrochloride.
-
FDA approval · 2023-02-21FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic Propafenone hydrochloride product from Aurobindo Pharma Limited under an Original Application. This marks market entr…
-
FDA approval · 2022-12-13FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' Esmolol hydrochloride in sodium chloride as a generic injectable under an Original Application (ANDA).
-
FDA approval · 2022-12-02FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (WG Critical Care, LLC)
FDA approved the original application for esmolol hydrochloride in saline (sodium chloride) solution, a generic injectable beta-blocker.
-
FDA approval · 2022-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved Slate Run Pharmaceuticals' generic diltiazem hydrochloride under an original ANDA.
-
FDA approval · 2022-06-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Lifestar Pharma LLC)
FDA approves a generic Verapamil Hydrochloride product from Lifestar Pharma LLC under an Original Application (ANDA).
-
FDA approval · 2022-05-05FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE — Original Application (Dr. Reddy's Labratories Inc.)
FDA approves Dr. Reddy's Laboratories' generic diltiazem hydrochloride extended-release tablet (ANDA 215775).
-
FDA approval · 2022-03-21FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approved the original application for esmolol hydrochloride in sodium chloride injection, a generic product manufactured by Eugia US LLC…
-
FDA approval · 2022-03-11FDA Approved: DIGOXIN — Original Application (Amici Pharma, Inc)
FDA approved the original ANDA for digoxin from Amici Pharma, authorizing a generic digoxin product.
-
FDA approval · 2021-12-20FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for Hospira's verapamil hydrochloride under an existing approved product, marking an update to t…